Symposia is supported by ILAE/CEA
Chair M.Bialer (Israel) and S. Kasradze (Georgia)
Contributors F. Vigevano (Italy), M.kokaia (Sweden), N.Specchio (Italy), M.Bialer (Israel), N.Tatishvili (Georgia)
Infantile epilepsy (IE) is one of more difficult to treat epilepsies and many aspects of this type of epilepsy are still under discussion. IE is characterised the high rate of comorbidity with different conditions and most frequently leads to severe disability that need multidisciplinary approach.
In addition, it causes increased physical and psychosocial morbidity and it imposes a large economic burden on health care systems.
The new ILAE classification of the epilepsies and the ILAE-Position paper of the ILAE Commission for Classification and Terminology, have engendered passionate debate. This is partly because it is built on the complex clinical constructs underpinning epilepsy diagnosis and partly because it is so critical to our daily practice.
Current proposals are based on a combination of the latest scientific understanding coupled with high-level expert opinion, including an extensive consultation with epilepsy professionals and the wider epilepsy community worldwide.
Classification defines some very important terms and definitions such as developmental and epileptic encephalopathies. Many aspects are not so easy to understand and even more difficult to implement in daily practice.
We think that this symposia will help multidisciplinary team members not only to better understand new concepts, but also will enhance their implementation in daily practice
Target audience: 70 participants
- F. Vigevano- Developmental and epileptic encephalopathies according new ILAE classification
- N. Speccio-Genetics of infantile epilepsies and new classification
- M. Bialer-New drugs
- M.Kokaia Biomarkers and mechanisms for epileptogenesis and ictogenesis
- N.Tatishvili New data on outcome of pediatric epilepsy